Fiche société
Kallyope Inc.
Traitements, essais et publications liés.
Traitements5programmes
Essais1liés
Publications4liées
SourceDBlocale
Traitements
5| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Elismetrep (K-304) 10 mgThis is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the acute treatment of migraine. | Migraine | Phase 2 | À vérifier | United States | À vérifier |
| Elismetrep (K-304) 2 mgThis is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the acute treatment of migraine. | Migraine | Phase 2 | À vérifier | United States | À vérifier |
| Elismetrep (K-304) 20 mgThis is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the acute treatment of migraine. | Migraine | Phase 2 | À vérifier | United States | À vérifier |
| Elismetrep (K-304) 5 mgThis is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the acute treatment of migraine. | Migraine | Phase 2 | À vérifier | United States | À vérifier |
| Elismetrep (K-304) 2 mgThis is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the acute treatment of migraine. | Migraine | Phase 2 | À vérifier | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Elismetrep (K-304) 2 mg | Migraine | Phase 2 | NCT06848075 | A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine | COMPLETED |
Publications
4| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Elismetrep (K-304) 5 mg | Interaction of magnolol with bovine serum albumin: a fluorescence-quenching study. | Analytical and bioanalytical chemistry | ||
| Elismetrep (K-304) 10 mg | Associative charge transfer reactions. Temperature effects and mechanism of the gas-phase polymerization of propene initiated by a benzene radical cation. | The journal of physical chemistry. A | ||
| Elismetrep (K-304) 10 mg | Thermodynamics, conformation and active sites of the binding of Zn-Nd hetero-bimetallic Schiff base to bovine serum albumin. | Journal of fluorescence | ||
| Elismetrep (K-304) 10 mg | Binding of dihydromyricetin to human hemoglobin: fluorescence and circular dichroism studies. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |